Leisure Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-8,558
Closed -$407K 129
2019
Q1
$407K Sell
8,558
-18
-0.2% -$792 0.34% 101
2018
Q4
$310K Sell
8,576
-365
-4% -$17.1K 0.29% 104
2018
Q3
$550K Sell
8,941
-938
-9% -$60.3K 0.45% 88
2018
Q2
$667K Sell
9,879
-7,094
-42% -$397K 0.57% 53
2018
Q1
$921K Sell
16,973
-313
-2% -$17.5K 0.81% 38
2017
Q4
$1.03M Buy
17,286
+380
+2% +$23K 0.86% 42
2017
Q3
$822K Sell
16,906
-2,298
-12% -$125K 0.72% 45
2017
Q2
$1.01M Sell
19,204
-613
-3% -$28.5K 0.9% 43
2017
Q1
$899K Sell
19,817
-2,605
-12% -$116K 0.8% 46
2016
Q4
$849K Sell
22,422
-3,259
-13% -$123K 0.76% 46
2016
Q3
$969K Sell
25,681
-150
-0.6% -$3.31K 0.91% 42
2016
Q2
$455K Buy
25,831
+34
+0.1% +$550 0.45% 59
2016
Q1
$314K Hold
25,797
0.31% 69
2015
Q4
$628K Buy
25,797
+616
+2% +$14.4K 0.57% 51
2015
Q3
$447K Buy
25,181
+14,206
+129% +$257K 0.49% 57
2015
Q2
$194K Buy
+10,975
New +$201K 0.19% 83

Other funds holding AERI

Leisure Capital Management's AERI Position: Q2 2019 in Review

Leisure Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q2 2019, closing a stake of 8,558 shares — an estimated $407K sold.

Leisure Capital Management first reported a position in AERI in Q2 2015 and held it in 16 quarters. The position peaked at $1.03M in Q4 2017. 167 funds tracked by Wall St. Rank hold AERI as of Q2 2019.

  • Leisure Capital Management reported no remaining Aerie Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Leisure Capital Management sold 8,558 Aerie Pharmaceuticals shares in Q2 2019, an estimated $407K.
  • Leisure Capital Management first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 16 quarters.
  • Leisure Capital Management's Aerie Pharmaceuticals position peaked at $1.03M in Q4 2017.
  • 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2019.

Based on Leisure Capital Management's 13F filing for Q2 2019, filed 10 Jul 2019.